Literature DB >> 19621973

Toward a new understanding of attention-deficit hyperactivity disorder: advances in research and treatment.

Thomas J Spencer1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19621973     DOI： 10.2165/00023210-200923000-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  30 in total

1.  Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Authors:  P J Santosh; G Baird; N Pityaratstian; E Tavare; P Gringras
Journal:  Child Care Health Dev       Date:  2006-09       Impact factor: 2.508

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

3.  Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.

Authors:  E Tahir; Y Yazgan; B Cirakoglu; F Ozbay; I Waldman; P J Asherson
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

4.  Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers.

Authors:  P Jäkälä; M Riekkinen; J Sirviö; E Koivisto; P Riekkinen
Journal:  Neuropsychopharmacology       Date:  1999-10       Impact factor: 7.853

5.  Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

Authors:  Russell E Scheffer; Robert A Kowatch; Thomas Carmody; A John Rush
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

Review 6.  Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.

Authors:  Lawrence Scahill
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 7.  Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Authors:  Sharon B Wigal
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

9.  Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.

Authors:  W Burleson Daviss; Nick C Patel; Adelaide S Robb; Michael P McDERMOTT; Oscar G Bukstein; William E Pelham; Donna Palumbo; Peter Harris; Floyd R Sallee
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-02       Impact factor: 8.829

10.  Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.

Authors:  Thomas J Spencer; F Randy Sallee; Donald L Gilbert; David W Dunn; James T McCracken; Barbara J Coffey; Cathy L Budman; Randall K Ricardi; Henrietta L Leonard; Albert J Allen; Denai R Milton; Peter D Feldman; Douglas K Kelsey; Daniel A Geller; Steven L Linder; Donald W Lewis; Paul K Winner; Roger M Kurlan; Mark Mintz
Journal:  J Atten Disord       Date:  2007-10-12       Impact factor: 3.256
View more
  1 in total

Review 1.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.

Authors:  Catharine A Winstanley
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.